Target intelligence / Profile preview

Coiled-coil domain-containing protein 85A (CCDC85A)

Target
CCDC85A
Molecular classification
Other (Coiled-coil domain-containing protein)
01

Overview

Coiled-coil domain-containing protein 85A (CCDC85A) is a member of the delta-interacting protein A (DIPA) family and encodes a protein characterized by coiled-coil motifs[1]. It is localized mainly at adherens junctions and the endoplasmic reticulum, where it interacts with proteins of the beta-catenin family and molecular chaperones such as GRP78 and GRP94[1][3][7]. CCDC85A modulates cell-cell adhesion, possibly epithelium development, and regulates the cellular response to ER stress by sustaining activation of the PERK pathway, facilitating cancer cell migration and invasiveness, and protecting cells from ER stress-induced apoptosis. High expression is linked to increased cancer cell resistance to drugs like cisplatin and may act as a mediator of tumor microenvironment adaptation[1][3][7]. Its regulation by miR-224-3p and possible detection in tumor fibroblasts and cancer cells also identifies CCDC85A as a possible biomarker and a candidate cellular target for overcoming drug resistance in oncology[1].

Other names
CCDC85AKIAA1912coiled-coil domain containing 85Acoiled-coil domain-containing protein 85ADIPA (delta-interacting protein A family member)
02

Mechanism of action

Not a direct pharmacological target, but modulation (e.g., by miR-224-3p or via exosomes) influences ER stress response and cisplatin resistance in cancer cells[1].

03

Biological functions

Cell-cell adhesionEpithelium developmentProtein bindingRegulation of endoplasmic reticulum (ER) stress responsePromotion of tumor cell migration and invasion
04

Disease associations

Cancer (implicated in gastric, pancreatic, and glioblastoma cell invasiveness and cisplatin resistance)Other (potential role in drug resistance and tumor microenvironment regulation)
05

Safety considerations

No notable safety concerns reported for targeting CCDC85A, but its broad role in ER stress resistance and cell adhesion suggests possible impact on normal tissue homeostasis if disrupted.
06

Interacting drugs

None specifically reported; however, resistance to cisplatin (a chemotherapeutic drug) is conferred by high CCDC85A activity[1].
07

Biomarkers

Elevated CCDC85A expression (potential biomarker of cisplatin resistance in some cancers)[1].Expression levels in cancer-associated fibroblasts and tumor cells[1].

Beyond the preview

Go deeper on Coiled-coil domain-containing protein 85A (CCDC85A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coiled-coil domain-containing protein 85A (CCDC85A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call